Envestnet Boosts Stake in Merck to Over Half a Billion Dollars

Envestnet Asset Management Inc., a prominent financial institution, has increased its stake in Merck & Co., Inc. (NYSE: MRK) by 3.7% in the second quarter, according to a recent Form 13F filing with the Securities and Exchange Commission.

The fund acquired an additional 143,914 shares during the quarter, bringing its total holdings to 3,996,890 shares of Merck & Co., Inc.'s stock, valued at approximately $513.60 million as of the most recent filing.

This significant investment is part of a larger trend in which institutional investors are increasing their positions in established companies like Merck & Co., Inc., which has a market capitalization of $365.31 billion and a price-to-earnings ratio of 118.46.